期刊文献+

新型TSPO分子探针18F-VUIIS1008探测活化小胶质细胞在炎性反应中的作用

Effect of a novel TSPO-targeted molecular probe 18F-VUIIS1008 in activated microglia cells of the inflammatory response
下载PDF
导出
摘要 目的:探讨外周型苯二氮[艹卓]受体转运蛋白(TSPO)的分子探针18F-VUIIS1008在不同条件下β淀粉样蛋白(Aβ)活化BV-2小胶质细胞的药代动力学特征及不同浓度地塞米松抑制后的药代动力学变化。方法:用小鼠的小胶质细胞BV-2细胞进行体外细胞摄取实验。不同浓度Aβ活化,在不同时间点测定BV-2细胞对18F-VUIIS1008的摄取率;在不同浓度地塞米松干预下,测定不同时间点BV-2细胞对18F-VUIIS1008的摄取率。结果:随着Aβ干预时间的延长和浓度的增加,BV-2细胞对18F-VUIIS1008摄取逐渐增加,12 h达到高峰,24 h略有下降。随着18F-VUIIS1008作用时间延长,BV-2细胞对18F-VUIIS1008摄取逐渐升高,60 min时达到最大摄取比值,90 min略有下降。其中在10.0μg/ml的Aβ活化12 h后加入18F-VUIIS1008作用60 min后Cin/Cout放射性比值最高,为2.08±0.40。在不同浓度的抗炎药物(地塞米松)作用下,随着时间的延长及地塞米松的浓度增加,Cin/Cout放射性比值逐渐减低。在100μmol/L地塞米松抑制下,BV-2小胶质细胞90 min对18F-VUIIS1008的摄取最低,为0.15±0.12。结论:Aβ可活化BV-2小胶质细胞,经典抗炎药物(地塞米松)可抑制小胶质细胞的活化。18F-VUIIS1008可能作为TSPO的分子探针,动态监测小胶质细胞的活化状态。 Objective To investigate the pharmacokinetics of uptaked the novel TSPO radiotracer 18F-VUIIS1008 by β amyloid protein(Aβ) activates BV-2 microglia cells under different conditions and after inhibition with different concertrations of dexamethasone in vitro cells.Method In vitro cellular uptake assay was performed on BV-2 microglia cells in mice.The uptake rate of 18F-VUIIS1008 in BV-2 cells was determined at different time poing after the activation of different concentration Aβ and the inhibition of different concentration dexamethasone.Results The uptake rate of 18F-VUIIS1008 increased gradually with the increasing of Aβ intervention time and its concentration.The uptake of the tracer reached the maximum at 12 hours, and then gradually decreased after 24 hours.The uptake increased gradully as the prolonged action time of 18F-VUIIS1008.It reached the peak value at 60 minutes, then it gradually decreased at 90 minutes.The uptake rate of the tracer also showed its maximum value was reached after 12 hours activation of 10.0 μg/ml Aβ and 60 minutes reaction of 18F-VUIIS1008(Cin/Cout was 2.08±0.40).The uptake decreased gradually with the concertration of anti-inflammatory(dexamethasone) increased over time.It also showed that the minimum value was reached after the inhibition of 100 μmol/L dexamethasone for 90 minutes(Cin/Cout was 0.15±0.12).Conclusion Aβ can activate BV-2 microglia cells, and anti-inflammatory drugs(dexamethasone) can inhibit the activation.The study suggests the potential value of 18F-VUIIS1008 being a novel molecular probe targeting TSPO to dynamically monitor the activation state for microglia.
作者 范群 苏福 杨荣水 马超 汤辉 张红 陈国强 FAN Qun;SU Fu;YANG Rong-shui(Department of Nuclear Medicine,Zhongshan Hospital,Xiamen University Xiamen Key Laboratory of Molecular Imaging Clinical Transformation of Nuclear Medicine Xiamen Nuclear Medicine Quality Control Center,Fujian Province,Xiamen 361000,China)
出处 《吉林医学》 CAS 2023年第3期573-577,共5页 Jilin Medical Journal
基金 福建省卫生计生青年科研课题[项目编号:2016-2-68]。
关键词 小胶质细胞 18F-VUIIS1008 外周型苯二氮[艹卓]受体转运蛋白 药代动力学 Microglia cells 18F-VUIIS1008 TSPO Pharmacokinetics
  • 相关文献

参考文献3

二级参考文献33

  • 1Papadopoulos V, Baraldi M, Guilarte TR, et al. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its struc- ture and molecular fimction [J]. Trends Pharmacol Sci, 2006, 27: 402-409.
  • 2Miccoli L, Poirson-Bichat F, Sureau F, et al. Potentiation of lonidamine and di- azepam, two agents acting on mitochondria, in human glioblastoma treatment [J]. J Natl Cancer Inst, 1998, 90:1400-1406.
  • 3Black KL, Shiraishi T, Ikezaki K, et al.Peripheral benzodiazepine stimulates secre- tion of growth hormone and mitochondrial proliferation in pituitary tumour GH3 cells [J]. Neurol Res, 1994, 16:74-80.
  • 4Wang JK, Morgan JI, Spector S. Differ- entiation of Friend erythroleukemia cells in- duced by benzodiazepines [J]. Proc Natl A- cad Sci U S A, 1984, 81: 3770- 3772.
  • 5Strittmatter WJ, Hirata F, Axelrod J, et al. Benzodiazepine and 13-adrenergic re- ceptor ligands independently stimulate phospholipid methyllation[J]. Nature, 1979, 282: 857-859.
  • 6Hardwick M, Fertikh D, Culty M, et al. Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression nuclear localization and PBR- mediated cell proliferation and nuclear transport of cholesterol [J]. Cancer Res, 1999, 59: 831-842.
  • 7Levin E, Prernkumar A, Veenman L, et al. The peripheral-type benzodiazepine re- ceptor and tumorigenicity: isoquinoline binding protein (IBP) antisense knock-down in the C6 glioma cell line[J]. Biochemistry, 2005, 44: 9924- 9935.
  • 8Lah LH. The mitochondrial benzodi- azepine receptor as a potential target protein for drug development: demonstration of functional significance with cell lines ex- hibiting differential expression of Bcl-2 [J]. Toxicol Sci, 2003, 74: 1-3.
  • 9Ryu JK, Choi HB, McLamon JG. Pe- ripheral benzodiazepine receptor ligand PK 11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat striatum [J]. Neurobiol Dis, 2005,20: 550-561.
  • 10Veiga S, Azcoitia I, Garcia-Segura LM. Ro5-4864, a peripheral benzodiazepine receptor ligand, reduces reactive gliosis and protects hippocampal hilar neurons from kainic acid excitotoxicity [J]. J Neurosci Res, 2005, 80: 129-137.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部